Globally-focused clinical-stage biopharmaceutical company developing first- and best-in-class targeted therapeutics for cancers, hepatitis B & age-related diseases. Ascentage is a leader in the design of small molecules therapeutics for targeting protein-protein interactions including Bcl-2, IAP and MDM2-p53. The company has 6 product candidates in clinical development.
9400 Key West Avenue, Suite 280
Rockville, MD 20850
Send Message to Request Information
Log in to download presentation, request a 1x1 meeting, view additional roadshows, and more.